Related Experiment Video
Updated: Apr 28, 2026

Quantification of Monocyte Chemotactic Activity In Vivo and Characterization of Blood Monocyte Derived Macrophages
Published on: August 12, 2019
Common Skin Diseases and Metabolic Syndrome: A Proinflammatory Chemokine Perspective
Mateusz Matwiejuk1, Hanna Myśliwiec1, Agnieszka Mikłosz2
1Department of Dermatology and Venerology, Medical University of Bialystok, 15-540 Bialystok, Poland.
Abstract:
Skin diseases frequently coexist with other disorders, such as metabolic syndrome, diabetes mellitus, depression, psoriatic arthritis, and cardiovascular disease. Altered levels of distinct chemokines, like CCL5/RANTES, CXCL12/SDF-1a, CCL7/MCP-3, CCL2/MCP-1, CXCL1/GROa, and the eotaxin family, contribute to the development and/or exacerbation of inflammation, which is a common feature of numerous skin diseases as well as metabolic syndrome. The pathological and molecular connections between chronic inflammatory skin diseases and metabolic syndrome are increasingly recognized as being driven by shared inflammatory pathways, oxidative stress, and adipokine dysregulation. While systemic inflammation acts as a common thread, the precise mechanisms for some conditions remain partially understood. Nevertheless, the exact pathological and molecular connections between skin diseases (i.e., psoriasis, atopic dermatitis, pemphigus vulgaris, acute and chronic spontaneous urticaria, bullous pemphigoid, squamous cell carcinoma, alopecia areata, systemic sclerosis, discoid lupus erythematosus, diffuse large B-cell lymphoma) and metabolic syndrome are not yet fully understood. This narrative review summarizes the robust association between various chronic inflammatory skin diseases and metabolic syndrome in the context of pro-inflammatory chemokines.
Insights
Chronic inflammatory skin diseases and metabolic syndrome share common inflammatory pathways. Pro-inflammatory chemokines play a key role in linking these conditions, impacting overall health.
Area of Science:
- Dermatology
- Immunology
- Metabolic Disorders
Background:
- Skin diseases often co-occur with metabolic syndrome, diabetes, and cardiovascular disease.
- Shared inflammatory pathways, oxidative stress, and adipokine dysregulation link chronic skin inflammation and metabolic syndrome.
Purpose of the Study:
- To review the association between chronic inflammatory skin diseases and metabolic syndrome.
- To highlight the role of pro-inflammatory chemokines in these interconnected conditions.
Main Methods:
- Narrative review of existing literature.
- Focus on pathological and molecular connections.
Main Results:
- Altered chemokine levels (e.g., CCL5, CXCL12, CCL2) contribute to inflammation in both skin diseases and metabolic syndrome.
- Systemic inflammation is a common factor, though precise mechanisms require further elucidation.
Conclusions:
- A robust association exists between various chronic inflammatory skin diseases and metabolic syndrome.
- Pro-inflammatory chemokines are crucial mediators in the pathophysiology linking these conditions.
More Related Videos
11:12Immunometabolic Circuits in Infection for Advancing Host Directed Therapies
Published on: September 13, 2024
08:47Induction of Experimental Autoimmune Encephalomyelitis in Mice and Evaluation of the Disease-dependent Distribution of Immune Cells in Various Tissues
Published on: May 8, 2016
Related Concept Videos
Inflammatory Bowel Disease III: Crohn's Disease
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Chronic Inflammation: Introduction
The Skin Microbiota
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease II: Ulcerative Colitis